2012Unpublished venueRequires access

Polycystic liver diseases

Luca Fabris, Catherine McCrann, Mario Strazzabosco

Open publisher page 1 citations

Abstract

Polycystic liver diseases are inherited disorders of the biliary epithelium, caused by genetic defects in ciliary- or endoplasmic reticulum-associated proteins. They are characterized by the formation and progressive enlargement of multiple cysts scattered throughout the liver parenchyma. Polycystic liver diseases may be classified into three main different clinical entities, based on the inheritance pattern and involvement of the kidney. Caroli disease and congenital hepatic fibrosis (along with recessive polycystic kidney diseases or ARPKD) are discussed elsewhere in the book. This chapter reviews the autosomal dominant polycystic liver disease with kidney involvement (ADPKD) or limited to the liver (PCLD). Despite extensive cyst substitution of the hepatic parenchyma, liver function is generally well preserved and portal hypertension is rare. The patients are asymptomatic, unless acute and chronic complications (including cyst infections or bleeding) develop. Diagnosis is usually radiological. Medical therapy is not currently available, but interventional radiology and surgical approaches, and, eventually, liver transplantation may be used in selected cases.

About this research paper

What this paper is about

Polycystic liver diseases are inherited disorders of the biliary epithelium, caused by genetic defects in ciliary- or endoplasmic reticulum-associated proteins. They are characterized by the formation and progressive enlargement of multiple cysts scattered throughout the liver parenchyma. Polycystic liver diseases may be classified into three main different clinical entities, based on the inheritance pattern and involvement of the kidney. Caroli disease and congenital hepatic fibrosis (along with recessive polycystic kidney diseases or ARPKD) are discussed elsewhere in the book. This chapter reviews the autosomal dominant polycystic liver disease with kidney involvement (ADPKD) or limited to the liver (PCLD). Despite extensive cyst substitution of the hepatic parenchyma, liver function is generally well preserved and portal hypertension is rare. The patients are asymptomatic, unless acute and chronic complications (including cyst infections or bleeding) develop. Diagnosis is usually radiological. Medical therapy is not currently available, but interventional radiology and surgical approaches, and, eventually, liver transplantation may be used in selected cases.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Polycystic liver diseases are inherited disorders of the biliary epithelium, caused by genetic defects in ciliary- or endoplasmic reticulum-associated proteins. They are characterized by the formation and progressive enlargement of multiple cysts scattered throughout the liver parenchyma. Polycystic liver diseases may be classified into three main different clinical entities, based on the inheritance pattern and involvement of the kidney. Caroli disease and congenital hepatic fibrosis (along with recessive polycystic kidney diseases or ARPKD) are discussed elsewhere in the book. This chapter reviews the autosomal dominant polycystic liver disease with kidney involvement (ADPKD) or limited to the liver (PCLD). Despite extensive cyst substitution of the hepatic parenchyma, liver function is generally well preserved and portal hypertension is rare. The patients are asymptomatic, unless acute and chronic complications (including cyst infections or bleeding) develop. Diagnosis is usually radiological. Medical therapy is not currently available, but interventional radiology and surgical approaches, and, eventually, liver transplantation may be used in selected cases.

Key concepts: Polycystic liver disease, Autosomal Recessive Polycystic Kidney Disease, Congenital hepatic fibrosis, Polycystic kidney disease, Cyst, Medicine, Pathology, Liver transplantation

Related papers

Back to paper searchBrowse research topicsOriginal source
Polycystic liver diseases — Research Paper | ScholarLens